Related Experiment Video
Updated: Aug 14, 2026
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Developments in the management of extremity soft tissue sarcomas
J Alexander Palesty1, William G Kraybill
1Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Abstract:
Soft tissue sarcomas, a rare and extremely low prevalence tumor, has no uniform treatment recommendation because there have been few randomized prospective trials to guide management. Recently, there have been surgical, medical, biologic, and genetic advances toward improved treatment. A multidisciplinary approach at specialized treatment centers should be sought because the skill set necessary to implement these advances can be provided and outcomes improved. Centralized care will be crucial to improving survival and functional outcome because it will allow for patients to be effectively entered into prospective randomized trials and create regional and national tissue banks to generate meaningful data.
Insights
Soft tissue sarcomas lack uniform treatment due to limited trials. Advances necessitate a multidisciplinary approach at specialized centers for improved outcomes and data generation.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Soft tissue sarcomas are rare tumors with no standard treatment guidelines.
- Limited randomized trials hinder evidence-based management strategies.
- Recent advances in surgery, medicine, biology, and genetics offer new treatment possibilities.
Purpose of the Study:
- To emphasize the need for a multidisciplinary approach in managing soft tissue sarcomas.
- To advocate for specialized treatment centers to leverage recent therapeutic advances.
- To highlight the importance of centralized care for improving patient survival and functional outcomes.
Main Methods:
- Review of recent surgical, medical, biologic, and genetic advances in sarcoma treatment.
- Discussion on the benefits of a multidisciplinary team approach.
- Emphasis on the role of specialized centers in patient management and data collection.
Main Results:
- Specialized centers can provide the necessary expertise for advanced sarcoma treatments.
- A multidisciplinary approach improves the implementation of novel therapies.
- Centralized care facilitates patient enrollment in clinical trials and tissue banking.
Conclusions:
- A multidisciplinary, centralized approach at specialized centers is crucial for optimizing soft tissue sarcoma care.
- Improved patient outcomes, including survival and function, are achievable through this model.
- Generation of robust data via prospective trials and tissue banks is essential for future treatment advancements.
